Oxytocin and Vasopressin Peptides Restore Social Behavior in a Prader-Willi Syndrome Mouse Model | Research

The takeaway

Oxytocin and vasopressin neuropeptides correct social-fear and aggression deficits in a Prader-Willi syndrome model by inhibiting somatostatin neurons in the lateral septum.

SST neuron inhibition corrects both social fear and aggression
Silencing overactive somatostatin neurons in the lateral septum restored social-fear extinction and suppressed aggression outbursts in the PWS mouse model, identifying a specific therapeutic target.

What the researchers found

In normal mice, oxytocin (OXT) and vasopressin (AVP) from the supraoptic nucleus promote inhibitory transmission in the lateral septum, keeping somatostatin (SST) neurons suppressed. In the Magel2 knockout mouse model of PWS, this neuropeptide signaling fails, causing SST neurons to become disinhibited. This disrupts social-fear extinction and triggers aggressive behavior.

The deficit mapped specifically to the supraoptic nucleus → lateral septum pathway. Optogenetic or pharmacological inhibition of SST neurons in the LS corrected social-fear extinction deficits and suppressed aggression outbursts, demonstrating a direct causal link and a potential therapeutic target.

Why it matters

Intranasal oxytocin has been explored as a treatment for social behavior problems in PWS and autism, but the brain mechanisms have been unclear. This study identifies the specific neural circuit — OXT/AVP → lateral septum SST neurons — and shows exactly how neuropeptide deficits cause social behavior disruptions. This provides a rational basis for developing targeted therapies that go beyond simply spraying oxytocin into the nose.

How the study worked

Researchers used the Magel2 knockout mouse model of PWS crossed with Cre-dependent transgenic lines for cell-type-specific manipulation. They employed optogenetics to activate or silence specific neural pathways, electrophysiology to measure synaptic transmission in the lateral septum, and pharmacological interventions in a social-fear-conditioning behavioral paradigm. Pathway-specific roles of OXT and AVP were mapped using circuit-tracing techniques.

What this study cannot tell us

This is a mouse study using a genetic model of PWS that may not perfectly replicate the human condition. The social-fear conditioning paradigm is a simplified model of complex human social behavior. While optogenetic and pharmacological manipulations are powerful, their translation to human therapies is not straightforward. The specific role of OXT versus AVP was not fully disentangled. Results from the Magel2KO model may not generalize to all forms of PWS or autism.

How to read the evidence

This is a rigorous preclinical mechanistic study published in Biological Psychiatry using multiple complementary techniques (optogenetics, electrophysiology, pharmacology). While the findings are compelling in mice, translation to human therapeutics requires further validation.

When this study was published

Published in 2024, this is recent work advancing the understanding of neuropeptide circuitry in social behavior disorders during a period of growing clinical interest in oxytocin-based therapies.

The bigger picture

Oxytocin and vasopressin are among the most studied neuropeptides in social behavior, but their clinical potential has been limited by an incomplete understanding of how and where they work in the brain. This study provides a circuit-level map of how these peptides control social behavior through the lateral septum, offering specific cellular targets (somatostatin neurons) for therapeutic intervention. The findings extend beyond PWS to potentially inform treatment of autism spectrum disorders more broadly.

Questions still open

Could drugs that specifically target somatostatin neurons in the lateral septum improve social behavior in PWS or autism patients?
Does intranasal oxytocin actually reach and affect lateral septum circuitry in humans?
Are SST neuron abnormalities in the lateral septum present in other forms of autism beyond PWS?

Common questions

What are oxytocin and vasopressin and why are they called 'social' peptides?

Oxytocin and vasopressin are neuropeptides — small proteins produced by the brain — that play major roles in social bonding, trust, and emotional behavior. Oxytocin is often called the 'love hormone' because it's released during social bonding. When these peptide signals are disrupted, as in Prader-Willi syndrome, social behavior problems including difficulty with social interactions and aggressive outbursts can result.

Could this research lead to treatments for autism?

Potentially. By identifying the specific brain circuit (oxytocin/vasopressin → lateral septum → somatostatin neurons) that controls social-fear responses, this study provides precise targets for drug development. Rather than broad oxytocin nasal sprays, future treatments might target somatostatin neurons specifically, potentially with fewer side effects and better efficacy. However, significant work is needed to translate these mouse findings to human therapies.

Read the original research

Disengagement of somatostatin neurons from lateral septum circuitry by oxytocin and vasopressin restores social-fear extinction and suppresses aggression outbursts in Prader-Willi syndrome model.

Biological psychiatry, 95(8), 785-799

View on PubMed ↗Publisher’s paper ↗

Citation

Dromard, Yann; Borie, Amélie M; Chakraborty, Prabahan; Muscatelli, Françoise; Guillon, Gilles; Desarménien, Michel G; Jeanneteau, Freddy. (2024). Disengagement of somatostatin neurons from lateral septum circuitry by oxytocin and vasopressin restores social-fear extinction and suppresses aggression outbursts in Prader-Willi syndrome model.. Biological psychiatry, 95(8), 785-799. https://doi.org/10.1016/j.biopsych.2023.10.016